Fund Holdings — Boxer Capital Management, LLC

Total Portfolio Value:
$313.73M
Total Bought:
$72.68M
Total Sold:
$85.20M
Net Transaction:
-$12.52M
Notable People:
Aaron Isaac Davis
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tango Therapeutics, Inc.(TNGX)9,771,4859,771,4850$50.03M$82.08M26.16%+$32.05M
uniQure N.V.SHS(QURE)899,500800,000-99,500$12.54M$46.70M14.88%+$34.16M
Revolution Medicines, Inc.(RVMD)792,977400,000-392,977$29.17M$18.68M5.95%-$10.49M
Kymera Therapeutics, Inc.(KYMR)432,010319,100-112,910$18.85M$18.06M5.76%-$791.9K
Kodiak Sciences Inc.(KOD)750,000750,0000$2.80M$12.28M3.91%+$9.48M
PTC Therapeutics, Inc.(PTCT)0200,000+200,000$0$12.27M3.91%+$12.27M
Amylyx Pharmaceuticals, Inc.(AMLX)1,225,000900,000-325,000$7.85M$12.23M3.90%+$4.38M
UroGen Pharma Ltd.(URGN)575,000575,0000$7.88M$11.47M3.66%+$3.59M
Merus N V365,000120,000-245,000$19.20M$11.30M3.60%-$7.90M
Cytokinetics, Incorporated(CYTK)0200,000+200,000$0$10.99M3.50%+$10.99M
ABIVAX Société AnonymeADS(ABVX)0120,000+120,000$0$10.19M3.25%+$10.19M
Protagonist Therapeutics Inc60,000110,000+50,000$3.32M$7.31M2.33%+$3.99M
Nektar Therapeutics(NKTR)125,000125,0000$3.23M$7.11M2.27%+$3.88M
Crescent Biopharma, Inc.(CBIO)453,686453,6860$7.32M$5.39M1.72%-$1.93M
Inovio Pharmaceuticals, Inc.(INO)02,300,000+2,300,000$0$5.38M1.72%+$5.38M
Sarepta Therapeutics, Inc.(SRPT)25,000250,000+225,000$427.5K$4.82M1.54%+$4.39M
Cidara Therapeutics Inc55,00048,000-7,000$2.68M$4.60M1.47%+$1.92M
Celcuity Inc.(CELC)090,000+90,000$0$4.45M1.42%+$4.45M
Replimune Group, Inc.(REPL)2,211,3411,050,000-1,161,341$20.54M$4.40M1.40%-$16.14M
Solid Biosciences Inc0600,000+600,000$0$3.70M1.18%+$3.70M
Denali Therapeutics Inc.(DNLI)0250,000+250,000$0$3.63M1.16%+$3.63M
Precigen, Inc.(PGEN)0850,000+850,000$0$2.80M0.89%+$2.80M
Apogee Therapeutics Inc050,000+50,000$0$1.99M0.63%+$1.99M
Mind Medicine Mindmed Inc0163,500+163,500$0$1.93M0.61%+$1.93M
MoonLake ImmunotherapeuticsCL A(MLTX)0250,000+250,000$0$1.79M0.57%+$1.79M
Nurix Therapeutics, Inc.(NRIX)175,000175,0000$1.99M$1.62M0.52%-$376.3K
Avalo Therapeutics, Inc.(AVTX)0125,000+125,000$0$1.59M0.51%+$1.59M
Milestone Pharmaceuticals Inc.(MIST)0666,666+666,666$0$1.33M0.42%+$1.33M
PepGen Inc.(PEPG)0250,000+250,000$0$1.16M0.37%+$1.16M
LB Pharmaceuticals Inc(LBRX)070,000+70,000$0$1.11M0.35%+$1.11M
Instil Bio, Inc.(TIL)70,70060,700-10,000$1.47M$1.08M0.35%-$388.6K
Kalvista Pharmaceuticals Inc93,40020,400-73,000$1.06M$248.5K0.08%-$807.4K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)266,666266,6660$72.0K$53.9K0.02%-$18.1K
Surrozen, Inc.W EXP 08 01 203(SRZN)66,66666,6660$1.2K$1.0K0.00%-$207
Iteos Therapeutics Inc825,0000-825,000$8.23M$0—-$8.23M
Page 1 of 1
Boxer Capital Management, LLC — 13F Holdings — Q3 2025 | TickerTrail